This trial is studying whether a medicine can improve symptoms in infants with a common breathing problem called laryngomalacia.
4 Primary · 6 Secondary · Reporting Duration: 1 year
Active Control
Experimental Treatment
160 Total Participants · 2 Treatment Groups
Primary Treatment: Speech Language Therapy · No Placebo Group · Phase 1 & 2
Age No minimum age - 6 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: